A cute gastroenteritis in infants and children is a common reason for visiting the emergency department (ED). Among children younger than 5 years old in the United States, gastroenteritis has been accounting for greater than 1.5 million outpatient visits, 200,000 hospital admissions, and nearly 300 deaths each year. 1 Dehydration remains the most frequent and serious complication of gastroenteritis. 2 The severity of dehydration was classified by the World Health Organization into 3 clinical categories: no dehydration (<5% weight loss), mild-to-moderate dehydration (5%-10% weight loss), and severe dehydration (≥10% weight loss). 3 A recent advance in the management of gastroenteritis has been changed to rapid oral rehydration therapy (ORT) for a 4-hour period, which was introduced as the first-line treatment for all children with gastroenteritis. 4 When oral rehydration is not feasible, intravenous (IV) rehydration with 20 mL/kg/h of 0.9% saline solution for 2 to 4 hours, followed by resumption of oral rehydration or continuous infusion of dextrose-containing solution at maintenance rate, seems adequate for initial rehydration of most patients requiring IV fluid therapy. 5 The World Health Organization recommends IV rehydration for 3 to 6 hours for children with severe dehydration due to gastroenteritis. 3 Rapid IV rehydration has been gradually incorporated into clinical practice by many emergency physicians aiming for rapid recovery and decreased length of stay in the overcrowded ED. 6 The objective of this study was to assess the efficacy of rapid IV rehydration compared with standard IV rehydration scheme in children with mildto-moderate dehydration secondary to acute gastroenteritis.
METHODS

Search Strategies and Data Sources
Eligible studies were identified using electronic databases and manual searches of the reference lists of included papers for potentially relevant articles, in addition to direct communications with experts in the field. MEDLINE/OVID SP (1946-September 2014), EMBASE/OVID SP (1974-September 2014), and Cochrane Central Register of Controlled Trials (CENTRAL) through The Cochrane Library (Issue 8, August 2014) were searched. A search strategy including a combination of the following medical subject heading (MeSH) terms and key words was used: "(gastroenteritis OR diarrhea) AND (dehydration OR rehydration) AND intravenous AND (rapid OR ultra-rapid) AND (children OR pediatrics)." The search limits included age from birth to 18 years, and no language restrictions were used.
Study Selection
Inclusion criteria were (1) randomized controlled trials describing rapid IV rehydration in children with mild-to-moderate dehydration secondary to acute gastroenteritis, (2) children from birth to 18 years old, and (3) standard IV rehydration therapy as comparator. Exclusion criteria were (1) studies describing children with severe dehydration, (2) noncomparative or descriptive studies as they are susceptible to bias and confounding factors, (3) studies describing ORTor nasogastric rehydration therapy, (4) studies of adult population, (5) animal studies, and (6) disease states other than gastroenteritis. Articles were screened by 2 independent investigators for relevance and eligibility criteria. Differences in selection were resolved through discussions between the reviewers.
Data Extraction
Data were extracted from each eligible study regarding the setting, design, study population, interventions, comparators, and outcomes. Outcome measures were defined a priori. The outcome measures were clinical rehydration, rate of hospitalization, ED length of stay, ED revisit, complications, and electrolyte imbalance.
Critical Appraisal
The quality and risk of bias in the eligible studies were assessed using the quality assessment tool for quantitative studies developed by the Effective Public Health Practice Project, Canada (http://www.city.hamilton.on.ca/phcs/EPHPP/). 7 The criteria of the tool consist of 6 domains: selection bias, allocation bias, confounders, detection bias, data collection methods, and attrition bias ( Table 1 ). The 6 components were rated as strong, moderate, or weak quality by 2 independent investigators, and the global quality ratings per study were totaled. The quality assignment for each study was rated as follows: strong (4 strong ratings with no weak ratings), moderate (less than 4 strong ratings and 1 weak rating), or weak (2 or more weak ratings). The interrater reliability for the raters was calculated for 3 studies using the κ statistic and was found to be excellent (κ = 0.85, P < 0.001).
Data Analysis
A meta-analysis of the randomized controlled trials was not feasible due to a paucity of eligible studies, heterogeneity of study design, variable outcome measures, and the risk of bias in the identified studies. The results of included studies have been summarized, tabulated, and evaluated for identified evidence. Quantitative variable mean values of serum electrolytes and blood sugar pretreatment and posttreatment were compared using the paired t test, and the results are presented together with 95% confidence intervals (CIs). Figure 1 demonstrates the selection process of articles in the review. Three trials, with a total of 464 participants, met the inclusion criteria, and their results were analyzed. In addition, a further analysis of the electrolyte values in 1 of the 3 studies was reviewed ( Table 2) .
RESULTS
Nager and Wang 8 conducted a pilot study to evaluate the ability of large-volume rapid IV fluids to rehydrate children aged 3 to 36 months with gastroenteritis. The patients were randomized to receive 50 mL/kg of 0.9% normal saline through either ultrarapid infusion for 1 hour or rapid infusion for 3 hours. The study was nonblinded and included only a small number of participants. Outcome measures were not clearly defined. Ultrarapid rehydration was well tolerated and similar to rapid hydration as suggested by the mean emesis volume (69 mL/h vs 63 mL/3 h, respectively), urine volume (93 mL/h vs 71 mL/3 h, respectively), and stool output (45 mL/h vs 75 mL/3 h, respectively; P = 0.042). The latter 2 results should be interpreted with caution because of the differences in the hydration time. The initial urine specific gravity (1.025) was the same in both treatment groups, with significantly different posthydration reduction in the ultrarapid method compared with standard hydration (1.015 vs 1.020, P = 0.028). Ultrarapid rehydration decreased the length of stay in the ED and allowed for earlier discharge from the ED than the standard rehydration method (2 vs 4 hours). No patients had serious complications, seizures, electrolyte disturbance, or overhydration related to fluid administration, although the study was not powered to assess potential safety concerns. One patient in each treatment group developed hypoglycemia in the postintervention phase. Of the ultrarapid patients discharged, 7 (15.6%) of 45 returned for additional treatment (six received oral fluids and one received IV fluids), and 6 (14.0%) of 43 of the standard patients returned (five treated with oral fluids and one treated with IV rehydration); all were improved. A double-blind clinical trial was conducted in the ED of a tertiary children's hospital in Canada by Freedman et al, 9 comparing large-volume versus standard-volume IV rehydration in children, aged 3 months to 11 years, with dehydration secondary to gastroenteritis. The sample size was large (226 children), and the method of randomization was clearly described. Children in whom oral rehydration failed were randomized (1:1 allocation) to either largevolume (60 mL/kg) or standard-volume (20 mL/kg) IV rehydration for 1 hour. The time limit of the oral rehydration trial before randomization and definition of treatment failure were not clearly described. Severity of dehydration was defined on the basis of a validated 8-point clinical dehydration scale. Outcome measures were clearly defined. The primary outcome was clinical hydration, as defined by a score of 1 or lower after 2 hours from the beginning of therapy. At 2 hours of treatment, hydration was achieved in 36% of patients receiving large-volume infusions versus 29% of those receiving standard-volume infusions (difference of 6.5%; 95% CI, −5.7% to 18.7%). At 4 hours, clinical rehydration was achieved in 69% of patients receiving either treatment (difference of 0.5%; 95% CI, −12.6% to 11.5%). Prolonged treatment was observed in 52% of large-volume versus 43% of standard-volume rehydration patients (difference of 8.9%; 95% CI, −5.0% to 21.0%). No clinically significant difference was observed between large-volume and standard rehydration regarding ED length of stay greater than 6 hours (35% vs 33%) or ED revisits requiring admission (6% vs 5%). One child developed hyponatremia in each group. Overhydration in the form of edemawas reported in 4 patients treated with the standard method and 2 patients by the large-volume approach, denoting inconsistent assessment of their dehydration severity. Subgroup analysis of children presenting with severe dehydration (baseline scores ≥ 5 on the clinical dehydration scale) and who achieved rehydration at 2 hours did not reveal greater clinical benefits of large-volume rehydration over standard rehydration. Children included in the large-volume fluid bolus arm had a longer median time-to-discharge compared with those treated with the standard method (6.3 vs 5.0 hours, P = 0.03). However, the significance level of P value was set to 0.01 for multiple testing. The frequency of ED revisits within 3 days was 14% in patients receiving large-volume rapid IV rehydration and 12% in those treated with the standard method (P = 0.69). Physician's comfort with discharge gave preference to the standard IV rehydration regimen. There was no evidence of clear clinical benefits of large-volume rapid rehydration, with the potential of worse outcome in patients receiving large-volume regimen.
The risk of developing hyponatremia when large-volume bolus fluid therapy was used for rehydrating children with gastroenteritis was evaluated by Freedman and Geary. 10 It was based on the same population as the study conducted by Freedman et al in 2011. 11 Children in whom ORT failed were randomized to either large-volume (60 mL/kg) or standard (20 mL/kg) IV rehydration using bolus 0.9% saline for 1 hour, followed by 0.9% saline for 3 hours at a maintenance rate. Outcome measures were clearly defined in the methodology, although it was a secondary analysis of previously collected data. Development of hyponatremia at 4 hours of treatment was the primary outcome measure. In both groups, similar numbers of children were hyponatremic at 4 hours of treatment (large volume, 21% [23/112]; standard, 20% [21/105]; P = 0.92). Among children with hyponatremia before the start of treatment, 63% (30/48) in the large-volume group and 44% (15/34) in the standard-volume group had improvement of their hyponatremia at 4 hours (P = 0.10). Children who received large-volume IV rehydration experienced a mean serum sodium increase of 2 mEq/L or greater (59/112 vs 39/105, P = 0.02) and were less likely to experience a sodium decrease of 2 mEq/L or greater (8/112 vs 17/105, P = 0.04) than those rehydrated with the standard method. At 4 hours of treatment, there was no difference in the number of children who developed hypernatremia (standard, 1/105; large, 3/112; P = 0.62). The most recent trial by Azarfar et al 11 compared rapid IV rehydration with standard 24-hour IV rehydration in children with moderate dehydration due to gastroenteritis. One hundred fifty children were randomized (1:1 ratio) to receive crystalloid solution either 20 to 30 mL/kg for 2 hours or 30 to 35 mL/kg for 4 hours. Outcome measures were not clearly defined. At 2 hours from starting IV fluids, 84% of patients in the rapid rehydration group were successfully rehydrated, vomiting resolved, and discharged. Two of 63 discharged patients had vomiting and readmitted to ED. In the standard rehydration group, 83% recovered from dehydration by the end of 4-hour infusion period, and three of them had persistent vomiting for more than 12 hours. No adverse events or complications were reported in both treatment groups.
Overall Result
Successful rehydration and ability to take oral fluids were achieved in 69% to 100% of both rapid and standard IV rehydration. Emergency department time to discharge ranged from 2 to 6 hours (rapid rehydration) versus 2 to 5 hours (standard method). The rates of electrolyte alterations ranged from 0.0% to 0.9% of both rapid and standard IV rehydration (Table 3 ). The frequency of ED revisits ranged from 3% to 16% (rapid rehydration) versus 5% to 14% (standard). The measurements of serum electrolytes in some studies showed significant changes in potassium, sodium, and blood sugar at 4 hours of treatment (Table 4) . None of the studies were sufficiently powered to assess safety concerns.
DISCUSSION
Despite superiority of oral rehydration, IV rehydration therapy for pediatric gastroenteritis is frequently practiced by emergency physicians. 12 Intravenous rehydration should be reserved for patients who fail ORT (insufficient intake, persistent vomiting, worsening diarrhea, or dehydration) or those with severe dehydration. 13 The possibility of electrolyte disturbance and the effects of fluid shift between intracellular and extracellular spaces with rapid fluid resuscitation remain potential safety concerns. The conditions that could be worsened by administration of large amount of fluids, such as hyponatremia/hypernatremia, are not common and might be not enrolled in available studies. The changes in serum electrolytes and blood sugar during IV rehydration were trivial or not clinically relevant during the short term of treatment. A recent trial by Levy et al 14 reported no clear evidence supporting dextrose administration during rapid IV rehydration. The new evidence of large-volume (60 mL/kg/h) bolus fluid therapy is inconsistent and fails to show any superiority over standard (20 mL/kg/h) IV rehydration. The possible explanation for failure of large-volume IV hydration to provide better clinical outcome is the hyperchloremic acidosis produced by large volumes of 0.9% normal saline, resulting in delay in recovery from dehydration. 15 Limitations of this Study Our systematic review is more rigorous and helps to address the gap in the literature regarding rapid IV rehydration volume compared with the review by Gorelick 16 in 2002. The evidence for standard IV rehydration scheme as a treatment strategy for children with gastroenteritis has been strengthened by the findings of new studies, with higher quality ratings, published in the last few years.
CONCLUSIONS
Overall, the new evidence regarding IV rehydration is not consistent. The discharge and readmission rates showed no consistent, statistically significant difference between the standard and rapid or ultrarapid rehydration approaches for children with dehydration due to gastroenteritis. When oral rehydration is not feasible, standard IV rehydration (20 mL/kg/h) for 1 to 4 hours followed by oral or maintenance IV fluids is adequate for most patients with uncomplicated gastroenteritis. Furthermore, large multicenter randomized trials are needed to achieve the optimal IV rehydration approach for pediatric gastroenteritis.
